Pictet Asset Management Sa Biocryst Pharmaceuticals Inc Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Sa holds 5,286,536 shares of BCRX stock, worth $39.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,286,536
Previous 5,618,372
5.91%
Holding current value
$39.8 Million
Previous $46.9 Million
20.57%
% of portfolio
0.04%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding BCRX
# of Institutions
278Shares Held
172MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$153 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$150 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$89.3 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$68.4 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$66.6 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.4B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...